Domain Partners VIII, L.P.

CIK 000146514412 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001465144

Recent Transactions

50 trades

Conversion
Bionano Genomics, Inc.$BNGO
Convertible Promissory Note
2018-08-23→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series C Preferred Stock
2018-08-23−5,426,808→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series B Preferred Stock
2018-08-23−6,810,098→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Common Stock
2018-08-23+591,184→ 591,184 total
Conversion
Bionano Genomics, Inc.$BNGO
Series D Preferred Stock
2018-08-23−6,396,105→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series D-1 Preferred Stock
2018-08-23−3,682,919→ 0 total
Purchase
Bionano Genomics, Inc.$BNGO
Warrants to Purchase Common Stock
2018-08-23+15,000→ 15,000 total
Conversion
Bionano Genomics, Inc.$BNGO
Common Stock
2018-08-23$4.59/sh+337,694→ 929,878 total
Purchase
Bionano Genomics, Inc.$BNGO
Common Stock
2018-08-23$6.13/sh+15,000→ 943,878 total
Conversion
Bionano Genomics, Inc.$BNGO
Series B-1 Preferred Stock
2018-08-23−2,986,762→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Redeemable Convertible Preferred Stock
2017-12-18−49,632→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Common Stock
2017-12-18$3.19/sh+1,678,432→ 3,431,139 total
Award
Dicerna Pharmaceuticals Inc
Common Stock
2017-12-18+37,890→ 3,469,029 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Common Stock
2017-12-11−988,285→ 0 total
Purchase
Dicerna Pharmaceuticals Inc
Redeemable Convertible Preferred Stock
2017-04-11$100.00/sh+49,632→ 49,632 total
Conversion
Syndax Pharmaceuticals Inc$SNDX
Series C-1 Preferred Stock
2016-03-08−360,640→ 0 total
Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2016-03-08+761,062→ 761,062 total
Conversion
Syndax Pharmaceuticals Inc$SNDX
Series B-1 Preferred Stock
2016-03-08−400,422→ 0 total
Conversion
GLAUKOS Corp$GKOS
Series E Preferred Stock
2015-06-30−589,100→ 0 total
Conversion
GLAUKOS Corp$GKOS
Common Stock
2015-06-30+876,083→ 876,083 total
Conversion
GLAUKOS Corp$GKOS
Series F Preferred Stock
2015-06-30−286,983→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Series E Preferred Stock
2015-05-12−887,073→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Common Stock
2015-05-12+1,807,820→ 1,807,820 total
Conversion
aTYR PHARMA INC$ATYR
Series C Preferred Stock
2015-05-12−12,143,933→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Series D Preferred Stock
2015-05-12−1,506,901→ 0 total
Disposition to Issuer
Durata Therapeutics, Inc.
Common Stock
2014-11-17−3,006,132→ 0 total
Conversion
Atara Biotherapeutics, Inc.$ATRA
Series A Preferred Stock
2014-10-21−1,272,607→ 0 total
Conversion
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2014-10-21+1,893,383→ 1,893,383 total
Conversion
Atara Biotherapeutics, Inc.$ATRA
Series B Preferred Stock
2014-10-21−620,776→ 0 total
Purchase
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2014-10-21$11.00/sh+248,159→ 2,141,542 total
Other
VERACYTE, INC.$VCYT
Common Stock
2014-09-10−300,000→ 2,763,294 total
Tax Payment
OTONOMY, INC.
Common Stock
2014-08-18$16.00/sh−37,224→ 1,579,323 total
Conversion
OTONOMY, INC.
Series C Preferred Stock
2014-08-18−925,479→ 0 total
Conversion
OTONOMY, INC.
Common Stock
2014-08-18+1,548,792→ 1,548,792 total
Tax Payment
OTONOMY, INC.
Series D Preferred Stock
2014-08-18−186,828→ 0 total
Conversion
OTONOMY, INC.
Series B Preferred Stock
2014-08-18−436,485→ 0 total
Exercise/Conversion
OTONOMY, INC.
Common Stock
2014-08-18$8.79/sh+67,755→ 1,616,547 total
Exercise/Conversion
OTONOMY, INC.
Series C Preferred Stock Warrant (Right to Buy)
2014-08-18−67,755→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Series B Preferred Stock
2014-02-04−476,464→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Series C Preferred Stock
2014-02-04−1,276,243→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Warrant
2014-02-04−21,041→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Warrant
2014-02-04+21,041→ 21,041 total
Conversion
Dicerna Pharmaceuticals Inc
Common Stock
2014-02-04+1,752,707→ 1,752,707 total
Conversion
VERACYTE, INC.$VCYT
Series C Preferred Stock
2013-11-04−680,972→ 0 total
Conversion
VERACYTE, INC.$VCYT
Series B Preferred Stock
2013-11-04−2,382,322→ 0 total
Conversion
VERACYTE, INC.$VCYT
Common Stock
2013-11-04+3,063,294→ 3,063,294 total
Other
ACHILLION PHARMACEUTICALS INC
Common Stock
2013-01-18−1,000,000→ 5,772,968 total
Conversion
Durata Therapeutics, Inc.
Common Stock
2012-07-24+2,227,596→ 2,227,596 total
Purchase
Durata Therapeutics, Inc.
Common Stock
2012-07-24$9.00/sh+778,536→ 3,006,132 total
Conversion
Durata Therapeutics, Inc.
Series A Preferred Stock
2012-07-24−2,227,596→ 0 total

Companies

Recent Filings

Address

C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE

PRINCETON, NJ, 08542

View on SEC.gov